Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AAGRNYSE:CTVANASDAQ:NOVSNASDAQ:YTEN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAAGRAfrican Agriculture$0.00-99.3%$0.01$0.00▼$0.41$1K-13.832,058 shs11,746 shsCTVACorteva$70.93+0.4%$63.29$50.01▼$71.10$48.39B0.723.31 million shs3.58 million shsNOVSNovus Capital$28.63$9.61▼$28.98$842KN/A370,842 shs10.17 million shsYTENYield10 Bioscience$0.02$0.02$0.31▼$17.26$11K1.4878,164 shsN/AThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAAGRAfrican Agriculture0.00%0.00%-24.62%+14,900.00%-96.08%CTVACorteva0.00%+2.53%+13.02%+17.47%+26.58%NOVSNovus Capital0.00%0.00%0.00%0.00%0.00%YTENYield10 Bioscience0.00%0.00%0.00%0.00%-99.21%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAAGRAfrican AgricultureN/AN/AN/AN/AN/AN/AN/AN/ACTVACorteva4.2912 of 5 stars2.35.02.51.03.41.71.9NOVSNovus CapitalN/AN/AN/AN/AN/AN/AN/AN/AYTENYield10 BioscienceN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAAGRAfrican Agriculture 0.00N/AN/AN/ACTVACorteva 2.69Moderate Buy$70.50-0.61% DownsideNOVSNovus Capital 0.00N/AN/AN/AYTENYield10 Bioscience 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NOVS, AAGR, YTEN, and CTVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2025CTVACortevaBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$64.00 ➝ $70.005/12/2025CTVACortevaWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$73.00 ➝ $79.005/9/2025CTVACortevaOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$72.00 ➝ $75.005/9/2025CTVACortevaCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$75.00 ➝ $78.005/9/2025CTVACortevaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$65.00 ➝ $71.005/9/2025CTVACortevaKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$71.00 ➝ $72.005/8/2025CTVACortevaUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$74.00 ➝ $76.004/14/2025CTVACortevaKeyCorpSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$70.00 ➝ $71.003/31/2025CTVACortevaArgusSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$69.00 ➝ $69.003/13/2025CTVACortevaThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$71.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAAGRAfrican Agriculture$1.75M0.00N/AN/A($2.39) per share0.00CTVACorteva$16.83B2.87$4.87 per share14.55$35.05 per share2.02NOVSNovus CapitalN/AN/AN/AN/AN/AN/AYTENYield10 Bioscience$60K0.18N/AN/A($4.97) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAAGRAfrican Agriculture-$43.06MN/A0.00∞N/AN/AN/AN/AN/ACTVACorteva$907M$1.6454.9820.801.685.36%7.19%4.26%8/6/2025 (Estimated)NOVSNovus CapitalN/AN/A0.00N/AN/AN/AN/AN/AN/AYTENYield10 Bioscience-$14.45M-$26.12N/A∞N/AN/AN/A-296.08%8/12/2025 (Estimated)Latest NOVS, AAGR, YTEN, and CTVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025CTVACorteva$0.88$1.13+$0.25$0.97$4.56 billion$4.42 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAAGRAfrican AgricultureN/AN/AN/AN/AN/ACTVACorteva$0.680.96%+6.92%41.46%5 YearsNOVSNovus CapitalN/AN/AN/AN/AN/AYTENYield10 BioscienceN/AN/AN/AN/AN/ALatest NOVS, AAGR, YTEN, and CTVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/30/2025CTVACortevaquarterly$0.171.1%6/2/20255/2/20256/16/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAAGRAfrican AgricultureN/AN/AN/ACTVACorteva0.081.450.93NOVSNovus CapitalN/A10.4810.48YTENYield10 BioscienceN/A0.160.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAAGRAfrican Agriculture20.52%CTVACorteva81.54%NOVSNovus Capital43.82%YTENYield10 Bioscience4.91%Insider OwnershipCompanyInsider OwnershipAAGRAfrican Agriculture48.40%CTVACorteva0.14%NOVSNovus CapitalN/AYTENYield10 Bioscience6.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAAGRAfrican Agriculture859.44 million4.87 millionNo DataCTVACorteva21,000682.17 million684.60 millionOptionableNOVSNovus CapitalN/A12.65 millionN/ANot OptionableYTENYield10 Bioscience30734,000689,000Not OptionableNOVS, AAGR, YTEN, and CTVA HeadlinesRecent News About These CompaniesYield10 Bioscience Files for Chapter 11 BankruptcyDecember 6, 2024 | tipranks.comYield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key ProposalsNovember 8, 2024 | accesswire.comYield10 Bioscience (OTC:YTEN) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comYield10 Bioscience (OTC:YTEN) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comYield10 Bioscience, Inc.: Yield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deYield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 14, 2024 | globenewswire.comNufarm buys Yield10’s camelina sativa investmentJuly 19, 2024 | graincentral.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comRothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in CamelinaJune 17, 2024 | globenewswire.comYield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide LabelMay 23, 2024 | globenewswire.comHold Rating on Yield10 Bioscience Amid Commercialization Challenges and Financial UncertaintiesMay 22, 2024 | markets.businessinsider.comYTEN Stock Earnings: Yield10 Bioscience Misses EPS, Misses Revenue for Q1 2024May 16, 2024 | investorplace.comYield10 Bioscience Shares Plumb New Depths After Nasdaq DelistingMay 15, 2024 | marketwatch.comYield10 Bioscience Announces First Quarter 2024 Financial ResultsMay 15, 2024 | globenewswire.comYield10 Bioscience Announces Delisting from NasdaqMay 15, 2024 | globenewswire.comYield10 Bioscience Sets 1-for-24 Reverse Stock SplitMay 1, 2024 | markets.businessinsider.comYield10 Bioscience to implement reverse stock splitMay 1, 2024 | msn.comYield10 Bioscience Announces 1-for-24 Reverse Stock SplitMay 1, 2024 | globenewswire.comYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call TranscriptApril 5, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNOVS, AAGR, YTEN, and CTVA Company DescriptionsAfrican Agriculture NASDAQ:AAGR$0.0001 -0.01 (-99.33%) As of 12:05 PM EasternAfrican Agriculture Holdings Inc., through its subsidiary Les Fermes de la Teranga SA, develops commercial farming business focusing on the production and sale of alfalfa for cattle feed and nutrition purposes in Africa. The company is based in New York, New York. African Agriculture Holdings Inc. is a subsidiary of Global Commodities & Investments Ltd.Corteva NYSE:CTVA$70.93 +0.30 (+0.42%) Closing price 03:59 PM EasternExtended Trading$70.96 +0.02 (+0.04%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.Novus Capital NASDAQ:NOVSNovus Capital Corporation is a blank check company. The company was founded in 2020 and is based in Indianapolis, Indiana.Yield10 Bioscience NASDAQ:YTEN$0.02 0.00 (0.00%) As of 05/30/2025Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Zscaler Will Hit $360 Soon: Here’s the How and Why Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
